Color Blindness, Blue
|
0.740 |
Biomarker
|
disease |
CTD_human |
|
|
|
Color Blindness, Blue
|
0.740 |
Biomarker
|
disease |
HPO |
|
|
|
Color Blindness, Blue
|
0.740 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Dyschromatopsia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal light-adapted electroretinogram
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Post-Traumatic Stress Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Conclusion</b>: i-CBT appears a potentially acceptable intervention for adults with PTSD.
|
31497259 |
2019 |
Acute lymphocytic leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
86.6% of the promoter-associated differentially methylated sites were hypermethylated in BCP ALL.
|
29125853 |
2017 |
Childhood Acute Lymphoblastic Leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
86.6% of the promoter-associated differentially methylated sites were hypermethylated in BCP ALL.
|
29125853 |
2017 |
Adult Acute Lymphocytic Leukemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
86.6% of the promoter-associated differentially methylated sites were hypermethylated in BCP ALL.
|
29125853 |
2017 |
Hepatitis C
|
0.010 |
Biomarker
|
disease |
BEFREE |
HCV infection was associated with changes in the nucleotide sequences of the binding site for the nuclear receptor family in HBV enhancer 2 (Enh2) including the BCP rather than Enh1.
|
15104371 |
2004 |
Leukemia, Myelocytic, Acute
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
AML samples were significantly more sensitive to tipifarnib compared to B-cell precursor ALL (BCP ALL) or N BM samples.
|
16051737 |
2005 |
Acute monocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
AML samples were significantly more sensitive to tipifarnib compared to B-cell precursor ALL (BCP ALL) or N BM samples.
|
16051737 |
2005 |
Hepatitis B
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Hepatitis B virus genotype distribution and genotype-specific BCP/preCore substitutions in acute and chronic infections in Argentina.
|
25822666 |
2015 |
Presenile dementia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Dementia caregivers' coping with pre-death grief: effects of a CBT-based intervention.
|
27792398 |
2018 |
Dementia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Dementia caregivers' coping with pre-death grief: effects of a CBT-based intervention.
|
27792398 |
2018 |
Thromboangiitis Obliterans
|
0.010 |
Biomarker
|
disease |
BEFREE |
TAO combines CBT and Positive Psychology strategies in order to provide patients with complete support, reducing their clinical symptoms and enhancing their capacity to overcome everyday adversity.
|
29855281 |
2018 |
Anxiety Disorders
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Anxiety disorders are common, yet treatment options in general practice are often limited to medication or CBT.
|
30012142 |
2018 |
Acute Chest Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ACS: acute chest syndrome; CBT: chronic blood transfusion; ELISA: enzyme-linked immunosorbent assay; FEV<sub>1</sub>: forced expiratory volume in 1 s; FVC: forced vital capacity; HPLC: high-density liquid chromatography; hs-CRP: highly sensitive C-reactive proteins; HU: hydroxyurea; IL: Interleukin; PEFR: peak expiratory flow rate; SEM: standard error of the mean; TLC: total lung capacity; 25-OHD: 25-hydroxyvitamin D; VOC: vaso-occlusive crisis; WGH: Wesley Guild Hospital.
|
30295174 |
2018 |
Coinfection
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
BCP mutations A1762T and G1764A were significantly more frequent in HBV genotype C mono-infection and the -1G frameshift was significantly more frequent in co-infection and was only observed in HBV genotype A co-infection.
|
20655563 |
2010 |
Acute hepatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
BCP/X, enhancer I and surface/polymerase variants were found to be associated almost exclusively with acute hepatitis.
|
23297244 |
2013 |
Liver Failure, Acute
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
BCP and PC variants were not associated with development of fulminant hepatic failure from HBV reactivation.
|
26943169 |
2016 |
Post-Traumatic Stress Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
CBT for Child PTSD is Associated with Reductions in Maternal Depression: Evidence for Bidirectional Effects.
|
27654496 |
2019 |
Mental Depression
|
0.100 |
Biomarker
|
disease |
BEFREE |
CBT for Child PTSD is Associated with Reductions in Maternal Depression: Evidence for Bidirectional Effects.
|
27654496 |
2019 |
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
CBT for Child PTSD is Associated with Reductions in Maternal Depression: Evidence for Bidirectional Effects.
|
27654496 |
2019 |
Depressed mood
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
CBT for Child PTSD is Associated with Reductions in Maternal Depression: Evidence for Bidirectional Effects.
|
27654496 |
2019 |